{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:51:28Z","timestamp":1776775888346,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["DS227"],"award-info":[{"award-number":["DS227"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114364","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T17:44:46Z","timestamp":1675446286000},"page":"114364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Interleukin 1\u03b1 and interleukin 18 in patients with vitiligo\u00a0\u2013 Results of a case-control study"],"prefix":"10.1016","volume":"160","author":[{"given":"Barbara","family":"Nieradko-Iwanicka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Przybylska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Borz\u0119cki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.114364_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114364_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.114364_bib3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4126","article-title":"A practical approach to the diagnosis and treatment of vitiligo in children","volume":"138","author":"Ezzedine","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.biopha.2023.114364_bib4","first-page":"55","article-title":"Quality of life in vitiligo patients","volume":"14","author":"Noor","year":"2004","journal-title":"J. Pak. Assoc. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114364_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051509","article-title":"Clinical and molecular aspects of vitiligo treatments","volume":"19","author":"Bishnoi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114364_bib6","first-page":"1","article-title":"Molecular and cellular basis of depigmentation in vitiligo patients","volume":"00","author":"Delmas","year":"2018","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114364_bib7","first-page":"1","article-title":"The vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.114364_bib8","first-page":"1421","article-title":"Roles of inflammation factors in melanogenesis (review)","volume":"21","author":"Fu","year":"2020","journal-title":"Mol. Med Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.114364_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114364_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.12998\/wjcc.v3.i3.221","article-title":"Highlights in pathogenesis of vitiligo","volume":"3","author":"Mohammed","year":"2015","journal-title":"World J. Clin. Cases"},{"issue":"NOV","key":"10.1016\/j.biopha.2023.114364_bib11","first-page":"591","article-title":"Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells","volume":"138","author":"Singh","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.biopha.2023.114364_bib12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/ijc.25182","article-title":"Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens","volume":"127","author":"Kholmanskikh","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.114364_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0167-4889(02)00320-8","article-title":"Summary and comparison of the signaling mechanisms of the Toll\/interleukin-1 receptor family","volume":"1592","author":"Martin","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2023.114364_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0923-1811(95)00418-1","article-title":"Regulation of keratinocyte growth factor gene expression in human skin fibroblasts","volume":"11","author":"Tang","year":"1996","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2023.114364_bib15","unstructured":"M. Grewe, K. Gyufko, A. Budnik, T. Ruzicka, S. Olaizola-Horn, M. Berneburg, J. Krutmann, Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation, J. Invest. Dermatol., vol. 107, 1996, pp. 865\u201370."},{"key":"10.1016\/j.biopha.2023.114364_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0625.1994.tb00263.x","article-title":"McKenzie RC. Differential modulation of interleukin-1 alpha (IL-1 alpha) and interleukin-1 beta (IL-1 beta) in human epidermal keratinocytes by UVB","volume":"3","author":"Kondo","year":"1994","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2023.114364_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1600-0625.2009.00957.x","article-title":"The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines","volume":"19","author":"Chen","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2023.114364_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.2969618","article-title":"cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily","volume":"241","author":"Sims","year":"1988","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biopha.2023.114364_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"9","author":"Laddha","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2023.114364_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4103\/ijdvl.IJDVL_1_17","article-title":"Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population","volume":"84","author":"Singh","year":"2018","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.biopha.2023.114364_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biocel.2012.11.008","article-title":"Interleukin-18 augments growth ability of primary human melanocytes by PTEN inactivation through the AKT\/NF-\u03baB pathway","volume":"45","author":"Zhou","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2023.114364_bib22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.tiv.2010.04.001","article-title":"JNK pathway is required for TNCB-induced IL-18 expression in murine keratinocytes","volume":"24","author":"Yun","year":"2010","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.biopha.2023.114364_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.autrev.2009.03.003","article-title":"IL-18 and skin inflammation","volume":"9","author":"Wittmann","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2023.114364_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jphotobiol.2016.08.024","article-title":"Cross-talk between interferon-gamma and interleukin-18 in melanogenesis","volume":"163","author":"Zhou","year":"2016","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.biopha.2023.114364_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5693572","article-title":"Increased serum levels of IFN-\u03b3, IL-1\u03b2, and IL-6 in patients with alopecia areata and nonsegmental vitiligo","volume":"2020","author":"Tomaszewska","year":"2020","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:54:28Z","timestamp":1776772468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222300152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":25,"alternative-id":["S075333222300152X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114364","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 1\u03b1 and interleukin 18 in patients with vitiligo\u00a0\u2013 Results of a case-control study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114364"}}